🤝 GARDP is proud to join forces with @dndi.org and @mmv.org to strengthen coordination, share expertise and accelerate the development of life-saving treatments for people worldwide. 📄 Learn more: gardp.org/dndi-gardp-a...

#PressRelease @dndi.org, @gardp.bsky.social and MMV are joining forces to strengthen collaboration, maximize the impact of global health R&D, and accelerate the development of life-saving treatments. Read the press release: bit.ly/4fo8xu0

Which of these can pooled procurement help reduce? A) Medicine shortages B) Costs C) Procurement risks D) All of the above

Great initiative from the ADVANCE-ID Network. Looking forward to the webinar and learning more about the upcoming open call. 👇

📍 At SADI 2026 in Argentina, GARDP joined PAHO, academic experts and health leaders to discuss financing and access to high-cost infectious disease therapies. The session highlighted the need to pair access with stewardship, surveillance and evidence generation.

🌍🎥 #ACC2026 session recordings are now available with subtitles in English, Japanese and Thai. From discovery to clinical development, revisit expert-led discussions across antimicrobial R&D — now more accessible globally. 🔗 Watch: acc-conference.com

Honoured to join fellow researchers and partners at an STI research event in Lusaka hosted by the Centre for Infectious Disease Research in Zambia (CIDRZ) and Zambia’s Ministry of Health.

👶💊 Investigators & partners just convened in Kuala Lumpur to prepare for the next phase of the NeoSep1 — a clinical trial tackling neonatal sepsis across Africa & Asia, where the burden is greatest and evidence is scarce. #AMR @innovative-ctu.bsky.social I @citystgeorges.bsky.social

🌍 At #WHA79, GARDP contributed to discussions on #AMR governance, sustainable financing, innovation and access. Thank you to @euinemergencies.ec.europa.eu, PAHO, ReActgroup, Roche, the @medicinespatentpool.org and partners advancing solutions to drug-resistant infections.

Antibiotics added 23 years to average human life expectancy. Drug resistance could take 1.8 back by 2035. GARDP's Dr Manica Balasegaram writes for World Economic Forum on why AMR is one of the most underestimated threats to global health and longevity. 🔗https://weforum.pulse.ly/moqskttcof

India beat polio when almost no one thought it could. Now it's taking on drug-resistant infections and in doing so could lead the world in tackling AMR. Dr Manica writes in Hindustan Times on why India's next big public health moment may already be underway. 🔗https://bit.pulse.ly/irmogfwcuw

🔬 GARDP participated in #Antibiotics2026 in Barcelona, sharing research on efflux pump inhibitors and their potential to restore antibiotic activity against drug-resistant Gram-negative bacteria. Great discussions on AMR, stewardship, One Health and innovative therapeutic strategies. 🌍🤝

GARDP is at the Philanthropy Asia Summit today — joining 1,000+ participants gathered around a shared question: how do we turn Asian innovation into global good? Come find us in the exhibition area if you are here. #PAS2026 #AsianInnovationGlobalGood #AMR #GlobalHealth

🌍 WHO-led global health architecture reform will shape how the world responds to future health threats. A new GARDP policy brief outlines key priorities for reform, from AMR and financing to implementation capacity and multilateral cooperation. 🔗https://gardp.pulse.ly/hvprd3xxsn @who.int

🦠AMR in Latin America is accelerating. In the latest Antimicrobial Viewpoint on #REVIVE, this is described as "molecular volcanic activity" with complex resistance patterns, shrinking treatment options and rising human cost. 🔗Full piece: revive.gardp.org/volcano-at-t... #AMR #GlobalHealth

Last week in Geneva, GARDP brought together 50+ partners in Geneva to help shape our 2027–2031 strategy. The consultation explored how we can strengthen collaboration, prioritize resources and maximize impact across AMR R&D and access. Thank you to all our partners for your presence and ideas.

Carol Ruffell of GARDP Africa joined a high-level dialogue at the @worldhealthsummit.bsky.social Regional Meeting 2026, co-hosted by Amref Health Africa and AHRIDA, on advancing regional health manufacturing in Africa. #WHS2026 #GlobalHealth #AMR

📚AMR has a language of its own, and it’s not always easy to keep up REVIVE’s Encyclopaedia helps break it down. In 2025, 31 new terms were added, reflecting how fast the field is evolving. If you’re learning, researching or just curious, this is a useful place. 🔍 https://bit.pulse.ly/drcpuei1iv

GARDP's Carol Ruffell will be part of a high-level panel co-hosted by Amref Health Africa and AHRIDA at the @worldhealthsummit.bsky.social Regional Meeting in Nairobi. 📅 29 April | 8:00–9:30 AM EAT 📍 UN Office, Nairobi + virtual 👉 Register via QR code in flyer #WHS2026 #GlobalHealth #Africa

Busy Q1 for the #REVIVE team 🧵👇Three webinars tackling some of the most pressing challenges in antimicrobial R&D. 🫁 Cystic fibrosis & chronic lung infections With the CF AMR Syndicate, this session explored why we need antimicrobials designed for the CF airway. 🔗🎥: revive.gardp.org/chronic-lung...

👋Closing out #ESCMIDGlobal Grateful for the many conversations over the past few days. 🙏 Thank you to everyone who joined us at the booth and poster sessions. Your questions and perspectives are what make these spaces meaningful. @escmid.bsky.social

Not every health system has the same tools. So why should AMR and sepsis strategies look the same everywhere? That's the question at the centre of Session 7 at the 6th #WorldSepsisCongress, moderated by GARDP's Justin Green. 🔗Join us online: www.youtube.com/live/KjawL3C... 📅23 April |🕣08:30 CEST

⌛Today marks the end of the exhibition at #ESCMID2026 If you're still around, we're at Booth G71 — we'd love to connect before the week closes.

Missed #ACC2026? All sessions are now available to watch. They cover how antibacterial R&D moves from early research to development, and where the gaps are. ▶️Watch here: acc-conference.com#agenda

Presenting our last poster at #ESCMIDGlobal today. 📍12:00–13:30, Poster Hall B3 Our poster looks at surveillance gaps in gonorrhoea across Cambodia, Thailand, Vietnam and South Africa — from missing regional data to limited resistance insights driven by diagnostic choices.

📄 Presenting today at 17:30 in Arena 3 at #ESCMIDGlobal. Our poster looks at carbapenem-resistant Klebsiella pneumoniae in South Africa where the resistance landscape is far more diverse and complex than a single strain story.

📄 We're presenting our first poster at #ESCMIDGlobal. 📍Poster Hall B3 Our South Africa work looks at how STI guidelines translate into practice and what shapes uptake on the ground. We're also exploring attitudes toward a new oral gonorrhoea treatment. If you’re at the conference, join us!

A lot will be shared at #ESCMIDGlobal. But some of the most important conversations happen between sessions. 🔴🪧 We’re at Booth G71 if you want to connect with our team. @escmid.bsky.social

🔴 We’re live at #ESCMIDGlobal 2026 Munich is now home to five days of conversations on AMR, infectious diseases, clinical microbiology and what comes next. Meet the team at Booth G71👋 @escmid.bsky.social

🤝 MSD and GARDP have signed a MoU to explore pathways for sustainable access to ceftolozane–tazobactam for the treatment of carbapenem-resistant Pseudomonas aeruginosa (CRPA).

Don't miss out on all the exciting research presented by your colleagues in the Poster Area in Hall B3! Poster sessions are everyday, Sat - Tues, 12:00-13:30 CEST. Poster Walkthrough sessions directly follow Sat - Mon, 13:30-14:30 CEST. See you there! https://ow.ly/FtWM50YI4S5

🚨 A significant step forward in newborn health GARDP’s #NeoSep1 trial has started in Ghana.

💻Join our #REVIVE webinar on natural product-inspired discovery exploring how approaches like symbiosis & metagenomics are pushing the boundaries of AMR research. Hear from experts + live Q&A 📅 28 April | ⏰ 09:30–11:00 CEST 🔗https://gotowebinar.pulse.ly/skkvdipmag @cbeemelmanns.bsky.social

We’ll be at #ESCMIDGlobal this April ✈️ If you’re in Munich, stop by Booth G71, attend our poster presentations and meet the GARDP team working across antibiotic R&D and access. 📅17–21 April | Munich @escmid.bsky.social

🔊 “Superbugs: Resistance Rising Part 3,” a new BBC World Service Discovery episode, features GARDP’s Seamus O’Brien and Bugworks’s Anand Anandkumar 🎧 Listen to the full episode: www.bbc.co.uk/programmes/w...

🌍GARDP at #OneHealthSummit AMR was highlighted as a growing global threat, with a push to move from commitments to implementation across stewardship & access. 👏We thank the French Government leadership in bringing #AMR to the G7 presidency forefront through this summit. 🔗Communiqué: bit.ly/41Z9kJQ

@ec.europa.eu DG HERA announced a €30 million investment managed by KfW, Germany’s Development Bank, to CARB-X and @gardp.bsky.social to strengthen the global response to AMR. CARB-X will fund early antibacterial research, while GARDP will advance clinical development. #IDSky 🧪 🔗 bit.ly/4v5K81M

🙌DG HERA announces €30M for CARB-X & GARDP, to be managed by KfW, Germany’s Development Bank. 🔬This new investment will be strengthening early #AMR research to late-stage clinical development. 🌍 A stronger drug development pipeline means better access to lifesaving treatments. 🔗 bit.ly/4so6KrR

✊ This #WorldHealthDay, standing with science means improving access and developing the treatments that are most needed. #TogetherForHealth #StandWithScience

⏳ 1 week to go for #GAMRIC2026 abstracts 📅 Deadline: 10 April, 12:00 CEST 🌍 Share your work on AMR, R&D, access or stewardship 🎤 Posters + lightning talks 🗂️ Preliminary programme now live 🔗 https://gamric.pulse.ly/byzzl0afrl

🆕A newly published piece in @natureportfolio.nature.com examines the NeoSep1 trial expansion led by GARDP Aiming to enrol 3,000+ newborns across Africa and Asia, the trial will generate evidence that clinicians can use immediately, leading to better outcomes for newborns. 🔗 bit.ly/4vbZ4LY

⚡Good news for #GAMRIC2026: the deadline for abstract submissions has been extended to 10 April 2026! We look forward to receiving your submissions! https://ow.ly/Vtx050YzIPo CARB-X, LifeArc, Global Antibiotic R&D Partnership (GARDP) #GAMRIC2026#IDSky #clinmicro

🌎 AMR needs regional solutions. In Brasília last week, GARDP joined partners to advance antibiotic access, stewardship and diagnostics. These efforts highlight the importance of country-led action and sustained collaboration to address AMR. #AMR #AntimicrobialResistance #GlobalHealth

Congratulations to @hitap.bsky.social on this important report 👇 Developed with @who.int and GARDP through SECURE, it looks at what coordinated procurement can deliver. At GARDP, we contributed insights based on our work on antibiotic access. 🔗Read the report: www.hitap.net/en/document/...

Great to join the EUP OHAMR General Assembly in Vienna We took part in a valuable WP4 discussion on capacity strengthening closely aligned with REVIVE’s work. Looking ahead to continued collaboration in its second year. @astridpm.bsky.social

🚨 Final week for GAMRIC submissions 📅 Deadline 31 March, 12:00 CEST If your work focuses on antimicrobial R&D, access, stewardship or diagnostics, this is a strong platform to share it. 🔗Submit your abstract here: https://gamric.pulse.ly/krrx8glctj

🧪 New open-access paper in @lancetmicrobe.bsky.social Co-authored by GARDP, @who.int and partners, this review identifies urgent gaps in diagnostics for bacterial priority pathogens with a focus on primary and secondary healthcare settings in LMICs. 📄🔗: https://sciencedirect.pulse.ly/rcmadx7q24

In Colombia, GARDP met partners to assess resistance patterns, surveillance and access to reserve antibiotics. 🏥 🤝 We identified key gaps and are advancing action to align R&D with regional priorities and strengthen access and stewardship.

📢 GARDP and Antabio partner to advance hit-to-lead antibiotic discovery. With few truly innovative drugs in the pipeline, advancing early research is key to tackling drug-resistant infections. 🔗 Read more: https://gardp.pulse.ly/ghuis8ftsg

📢 #REVIVE hosts a webinar spotlighting four new publications shaping antimicrobial R&D. 📅 26 March 2026 |⏱️11:00 AM-12:30 PM 🔗 Register: https://gotowebinar.pulse.ly/zpoex6imq5